Living Donor Intestinal Transplantation: Recipient Outcomes

Objective: To examine outcomes of living-donor intestinal transplant (LDITx) recipients. Background: LDITx is not routinely performed because of surgical risks to the donor and the potential inferior physiologic performance of the segmental graft. However, data on the effectiveness of LDITx are scarce. Design: This retrospective cohort study included patients undergoing LDITx between May 1999 and December 2021 in intestinal transplant programs in 2 university-affiliated hospitals in China. Results: Actuarial survival rates were 80%, 72.7%, 66.7% for patient and 72.4%, 63.6%, 60% for graft at 1, 3, and 5 years, respectively. Recipients with>3/6 HLA-matched grafts had superior patient and graft survival rates than those with ≤3/6 HLA-matched grafts (P
Source: Annals of Surgery - Category: Surgery Tags: Original Articles Source Type: research